Literature DB >> 11045893

Structure-activity relationships for the inhibition of lipid peroxidation and the scavenging of free radicals by synthetic symmetrical curcumin analogues.

P Venkatesan1, M N Rao.   

Abstract

A number of ring substituted analogues of curcumin were synthesized. Their antioxidant properties were studied using three models, inhibition of lipid peroxidation, scavenging of 1,1'-diphenyl-2-picrylhydrazyl (DPPH) and 2,2'-azinobis(3-ethyl-benzthiazoline-6-sulphonate radical (ABTS+.). In all the models, the phenolic analogues were more active than the non-phenolic analogues, some of which were inactive. The highest antioxidant activity was obtained when the phenolic group was sterically hindered by the introduction of two methyl groups at the ortho position. This and several other compounds were more active than the standard antioxidants alpha-tocopherol and trolox. This study has demonstrated that the phenolic group is important for the antioxidant activity of curcumin and that the structural features that enhance the antioxidant properties of phenols are optimized in curcumin to a significant extent.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11045893     DOI: 10.1211/0022357001774886

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  15 in total

1.  Curcumin overcomes the inhibitory effect of nitric oxide on Leishmania.

Authors:  Marion Man-Ying Chan; Naga Suresh Adapala; Dunne Fong
Journal:  Parasitol Res       Date:  2005-03-17       Impact factor: 2.289

2.  Different curcuminoids inhibit T-lymphocyte proliferation independently of their radical scavenging activities.

Authors:  Michael Deters; Heiko Knochenwefel; Daniel Lindhorst; Therese Koal; Hartmut H Meyer; Wolfram Hänsel; Klaus Resch; Volkhard Kaever
Journal:  Pharm Res       Date:  2008-04-22       Impact factor: 4.200

Review 3.  Neuroprotective effects of curcumin.

Authors:  Greg M Cole; Bruce Teter; Sally A Frautschy
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

4.  Neuroprotective and antiinflammatory properties of a novel demethylated curcuminoid.

Authors:  Savita Khanna; Han-A Park; Chandan K Sen; Trimurtulu Golakoti; Krishanu Sengupta; Somepalli Venkateswarlu; Sashwati Roy
Journal:  Antioxid Redox Signal       Date:  2009-03       Impact factor: 8.401

5.  Curcumin affords neuroprotection and inhibits α-synuclein aggregation in lipopolysaccharide-induced Parkinson's disease model.

Authors:  Neha Sharma; Bimla Nehru
Journal:  Inflammopharmacology       Date:  2017-10-12       Impact factor: 4.473

6.  Hepatoprotective activities of picroliv, curcumin, and ellagic acid compared to silymarin on carbon-tetrachloride-induced liver toxicity in mice.

Authors:  C Girish; S C Pradhan
Journal:  J Pharmacol Pharmacother       Date:  2012-04

7.  Recent advances in the investigation of curcuminoids.

Authors:  Hideji Itokawa; Qian Shi; Toshiyuki Akiyama; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Chin Med       Date:  2008-09-17       Impact factor: 5.455

8.  ¹H-NMR and MS based metabolomics study of the intervention effect of curcumin on hyperlipidemia mice induced by high-fat diet.

Authors:  Ze-Yun Li; Li-Li Ding; Jin-Mei Li; Bao-Li Xu; Li Yang; Kai-Shun Bi; Zheng-Tao Wang
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

Review 9.  Presenting a New Standard Drug Model for Turmeric and Its Prized Extract, Curcumin.

Authors:  Franco Cavaleri
Journal:  Int J Inflam       Date:  2018-01-15

Review 10.  Nanoformulations of curcumin: an emerging paradigm for improved remedial application.

Authors:  Meeta Gera; Neelesh Sharma; Mrinmoy Ghosh; Do Luong Huynh; Sung Jin Lee; Taesun Min; Taeho Kwon; Dong Kee Jeong
Journal:  Oncotarget       Date:  2017-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.